2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruf, R. G. Articles by the Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group, Search for Related Content PubMed PubMed Citation Articles by Ruf, R. G. Articles by the Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group, Related Collections Related Article

Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome

Rainer G. Ruf^*,, Anne Lichtenberger^*, Stephanie M. Karle, Johannes P. Haas, Franzisco E. Anacleto^||, Michael Schultheiss^*, Isabella Zalewski^*, Anita Imm^¶, Eva-Maria Ruf^¶, Bettina Mucha^*, Arvind Bagga^#, Thomas Neuhaus^**, Arno Fuchshuber^¶, Aysin Bakkaloglu, Friedhelm Hildebrandt^* and the Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group

*Departments of Pediatrics and Human Genetics, University of Michigan, Ann Arbor, Michigan; University Children’s Hospital, Duesseldorf, Germany; University Children’s Hospital, Erlangen, Germany; University Children’s Hospital, Greifswald, Germany; ^||Section of Pediatric Nephrology, Department of Pediatrics, University of the Philippines-Philippine General Hospital, Medical Center, Manila, Philippines; ^¶University Children’s Hospital, Freiburg, Germany; ^#University Children’s Hospital, New Delhi, India; **University Children’s Hospital, Zurich, Switzerland; and Hacettepe University School of Medicine, Ankara, Turkey.

Correspondence to Dr. Friedhelm Hildebrandt, University of Michigan Health System, 8220C MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0646. Phone: 734-615-7285; Fax: 734-615-1386; E-mail: fhilde{at}umich.edu

ABSTRACT. Nephrotic syndrome (NS) represents the association of proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Steroid-resistant NS (SRNS) is defined by primary resistance to standard steroid therapy. It remains one of the most intractable causes of ESRD in the first two decades of life. Mutations in the NPHS2 gene represent a frequent cause of SRNS, occurring in approximately 20 to 30% of sporadic cases of SRNS. On the basis of a very small number of patients, it was suspected that children with homozygous or compound heterozygous mutations in NPHS2 might exhibit primary steroid resistance and a decreased risk of FSGS recurrence after kidney transplantation. To test this hypothesis, NPHS2 mutational analysis was performed with direct sequencing for 190 patients with SRNS from 165 different families and, as a control sample, 124 patients with steroid-sensitive NS from 120 families. Homozygous or compound heterozygous mutations in NPHS2 were detected for 43 of 165 SRNS families (26%). Conversely, no homozygous or compound heterozygous mutations in NPHS2 were observed for the 120 steroid-sensitive NS families. Recurrence of FSGS in a renal transplant was noted for seven of 20 patients with SRNS (35%) without NPHS2 mutations, whereas it occurred for only two of 24 patients with SRNS (8%) with homozygous or compound heterozygous mutations in NPHS2. None of 29 patients with homozygous or compound heterozygous mutations in NPHS2 who were treated with cyclosporine A or cyclophosphamide demonstrated complete remission of NS. It was concluded that patients with SRNS with homozygous or compound heterozygous mutations in NPHS2 do not respond to standard steroid treatment and have a reduced risk for recurrence of FSGS in a renal transplant. Because these findings might affect the treatment plan for childhood SRNS, it might be advisable to perform mutational analysis of NPHS2, if the patient consents, in parallel with the start of the first course of standard steroid therapy.

Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2004 15: A24-A26. [Full Text] [PDF]

This article has been cited by other articles:

				S. F. Heeringa, C. N. Vlangos, G. Chernin, B. Hinkes, R. Gbadegesin, J. Liu, B. E. Hoskins, F. Ozaltin, F. Hildebrandt, and Members of the APN Study Group Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3527 - 3533. [Abstract] [Full Text] [PDF]

				A. Philippe, F. Nevo, E. L. Esquivel, D. Reklaityte, O. Gribouval, M.-J. Tete, C. Loirat, J. Dantal, M. Fischbach, C. Pouteil-Noble, et al. Nephrin Mutations Can Cause Childhood-Onset Steroid-Resistant Nephrotic Syndrome J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1871 - 1878. [Abstract] [Full Text] [PDF]

				J. Ratelade, T. A. Lavin, A. O. Muda, L. Morisset, G. Mollet, O. Boyer, D. S. Chen, A. Henger, M. Kretzler, N. Hubner, et al. Maternal Environment Interacts with Modifier Genes to Influence Progression of Nephrotic Syndrome J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1491 - 1499. [Abstract] [Full Text] [PDF]

				M. P. Winn 2007 Young Investigator Award: TRP'ing into a New Era for Glomerular Disease J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1071 - 1075. [Abstract] [Full Text] [PDF]

				B. Hinkes, C. Vlangos, S. Heeringa, B. Mucha, R. Gbadegesin, J. Liu, K. Hasselbacher, F. Ozaltin, F. Hildebrandt, and and Members of the APN Study Group Specific Podocin Mutations Correlate with Age of Onset in Steroid-Resistant Nephrotic Syndrome J. Am. Soc. Nephrol., February 1, 2008; 19(2): 365 - 371. [Abstract] [Full Text] [PDF]

				M. R. Pollak, M. P. Alexander, and J. M. Henderson A Case of Familial Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1367 - 1374. [Full Text] [PDF]

				L. M. McKenzie, S. L. Hendrickson, W. A. Briggs, R. A. Dart, S. M. Korbet, M. H. Mokrzycki, P. L. Kimmel, T. S. Ahuja, J. S. Berns, E. E. Simon, et al. NPHS2 Variation in Sporadic Focal Segmental Glomerulosclerosis J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2987 - 2995. [Abstract] [Full Text] [PDF]

				J. H. H. Ehrich, C. Geerlings, M. Zivicnjak, D. Franke, H. Geerlings, and J. Gellermann Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2183 - 2193. [Abstract] [Full Text] [PDF]

				J. A. Jefferson and S. J. Shankland Familial nephrotic syndrome: PLCE1 enters the fray Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1849 - 1852. [Full Text] [PDF]

				L. Barisoni, H. W. Schnaper, and J. B. Kopp A Proposed Taxonomy for the Podocytopathies: A Reassessment of the Primary Nephrotic Diseases Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 529 - 542. [Abstract] [Full Text] [PDF]

				B. G. Hinkes, B. Mucha, C. N. Vlangos, R. Gbadegesin, J. Liu, K. Hasselbacher, D. Hangan, F. Ozaltin, M. Zenker, F. Hildebrandt, et al. Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2) Pediatrics, April 1, 2007; 119(4): e907 - e919. [Abstract] [Full Text] [PDF]

				N. He, A. Zahirieh, Y. Mei, B. Lee, S. Senthilnathan, B. Wong, B. Mucha, F. Hildebrandt, D. E. Cole, D. Cattran, et al. Recessive NPHS2 (Podocin) Mutations Are Rare in Adult-Onset Idiopathic Focal Segmental Glomerulosclerosis Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 31 - 37. [Abstract] [Full Text] [PDF]

				A. Kitamura, H. Tsukaguchi, K. Iijima, J. Araki, M. Hattori, M. Ikeda, M. Honda, K. Nozu, H. Nakazato, N. Yoshikawa, et al. Genetics and clinical features of 15 Asian families with steroid-resistant nephrotic syndrome Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3133 - 3138. [Full Text] [PDF]

				S Fujinaga, K Kaneko, T Muto, Y Ohtomo, H Murakami, and Y Yamashiro Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome Arch. Dis. Child., August 1, 2006; 91(8): 666 - 670. [Abstract] [Full Text] [PDF]

				K. Tryggvason, J. Patrakka, and J. Wartiovaara Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med., March 30, 2006; 354(13): 1387 - 1401. [Full Text] [PDF]

				M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications? J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387. [Full Text] [PDF]

				C. Herve and J. Dantal Possible new perspectives for our understanding of nephrotic syndrome recurrence Nephrol. Dial. Transplant., January 1, 2006; 21(1): 10 - 13. [Full Text] [PDF]

				C. M. Meyers, M. Geanacopoulos, L. B. Holzman, and D. J. Salant Glomerular Disease Workshop J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3472 - 3476. [Abstract] [Full Text] [PDF]

				A. Weins, P. Kenlan, S. Herbert, T. C. Le, I. Villegas, B. S. Kaplan, G. B. Appel, and M. R. Pollak Mutational and Biological Analysis of {alpha}-Actinin-4 in Focal Segmental Glomerulosclerosis J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3694 - 3701. [Abstract] [Full Text] [PDF]

				Z. Yu, J. Ding, J. Huang, Y. Yao, H. Xiao, J. Zhang, J. Liu, and J. Yang Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children Nephrol. Dial. Transplant., May 1, 2005; 20(5): 902 - 908. [Abstract] [Full Text] [PDF]

				A. Meyrier Nephrotic focal segmental glomerulosclerosis in 2004: an update Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2437 - 2444. [Full Text] [PDF]

				P. Niaudet Podocin and Nephrotic Syndrome: Implications for the Clinician J. Am. Soc. Nephrol., March 1, 2004; 15(3): 832 - 834. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673